With many around the world affected by the COVID-19, pharmaceutical companies are boosting their production capabilities to develop vaccines. Such trends are creating revenue opportunities for players in the serum-free media market.
With many around the world affected by the COVID-19, pharmaceutical companies are boosting their production capabilities to develop vaccines. Such trends are creating revenue opportunities for players in the serum-free media market. Lonza Group - a Swiss multinational chemicals and biotechnology company, is gaining recognition for its ProVeroTM1 Serum-free Medium, which is of non-animal origin and supports vaccine production.
https://www.transparencymarketresearch.com/serum-free-media-market.html
